Kyleena 19.5 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FCFL3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,384
Award facts
- Contract value 100% obligated
- $11,383.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,383.74 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Kyleena 19.5 mg contraceptive systems. The delivery order, issued on November 28, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a regional prime vendor contractor supporting Department of Defense pharmaceutical supply needs globally through December 31, 2036.
The PPV-G GEN V represents a critical component of the broader $30.3 billion pharmaceutical supply strategy for the Department of Defense, authorizing DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders for specialized pharmaceutical products, including oncology treatments, biologics, vaccines, and medical devices, demonstrates its capability to fulfill the diverse requirements of the federal military medical system with no identified subcontractor relationships in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FCFL3?
SPE2DR26FCFL3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FCFL3 worth?
The government has obligated $11,384 on SPE2DR26FCFL3.
Is contract SPE2DR26FCFL3 an order under another contract?
Yes. SPE2DR26FCFL3 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFL3 competed?
The extent of competition for SPE2DR26FCFL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award